Novavax
NVAX
#4816
Rank
S$2.69 B
Marketcap
S$16.33
Share price
15.80%
Change (1 day)
46.59%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -S$0.29 Billion

According to Novavax's latest financial reports the company's current earnings are S$0.41 Billion. In 2025 the company made an earning of S$0.59 Billion, an increase over its 2024 earnings that were of -S$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.29 Billion-148.5%
2025 S$0.59 B-396.87%
2024 -S$0.21 Billion-70.39%
2023 -S$0.68 Billion-16.59%
2022 -S$0.82 Billion-62.58%
2021 -S$2.17 Billion320.54%
2020 -S$0.52 Billion234.22%
2019 -S$0.16 Billion-30.17%
2018 -S$0.23 Billion1.69%
2017 -S$0.22 Billion-36.44%
2016 -S$0.35 Billion70.4%
2015 -S$0.21 Billion89.27%
2014 -S$0.11 Billion59.83%
2013 -S$66.33 Million81.9%
2012 -S$36.47 Million50.33%
2011 -S$24.26 Million
2009 -S$47.87 Million8.8%
2008 -S$44 Million18.01%
2007 -S$37.29 Million18.33%
2006 -S$31.51 Million168.31%
2005 -S$11.75 Million-62.51%
2004 -S$31.33 Million52.4%
2003 -S$20.56 Million-28.21%
2002 -S$28.63 Million
2000 -S$16.32 Million177%
1999 -S$5.89 Million-11.54%
1998 -S$6.66 Million10.64%
1997 -S$6.02 Million-9.62%
1996 -S$6.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$19.87 B-7,047.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$8.84 B-3,191.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$18.35 B-6,514.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$10.10 B-3,631.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-S$0.17 Billion-41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.42 Billion 45.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$0.19 B-167.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-S$10.36 Million-96.38%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$0.49 Billion 70.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-S$0.13 Billion-57.43%๐Ÿ‡บ๐Ÿ‡ธ USA